The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia

Controlled Clinical Trials

Volumn 19, Issue 6, 1998, Pages 604-621

  Shumaker, Sally A ^a   Reboussin, Beth A ^a   Espeland, Mark A ^a   Rapp, Stephen R ^a   McBee, Wendy L ^a   Dailey, Maggie ^a   Bowen, Deborah ^b   Terrell, Tim ^a   Jones, Beverly N ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

Aging; Alzheimer's; Cognitive impairment; Dementia; Estrogen

Indexed keywords

ESTROGEN; GESTAGEN; PLACEBO;

AGED; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; DEMENTIA; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEMORY; MULTICENTER STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0032430616     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(98)00038-5     Document Type: Article

References (61)

1. 1. Evans DA, Funkenstein H, Albert MS. Prevalence of Alzheimer's disease in a community population of older persons. JAMA 1989;262:2551-2556.
2. 2. Cummings JL, Benson DF. Dementia: A Clinical Approach, 2nd ed. Boston: Butterworth; 1992.
3. 3. Cummings JL, Benson DF, Hill MA. Aphasia in dementia of Alzheimer's type. Neurology 1985;35:394-397.
4. 4. Bachman DL, Wolf PA, Linn R. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 1992;42:115-119.
5. 5. Birge SJ. Alzheimer's disease research: possible causes, potential treatment. Poster book, American Academy of Family Physicians, New Orleans, 1996.
6. 6. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995;273:1354-1359.
7. 7. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population. The Framingham Study. Neurology 1993;43: 515-519.
8. 8. Morgan K, Lilley J, Arie T, et al. Incidence of dementia: preliminary findings from the Nottingham Longitudinal Study of Activity and Aging. Neuroepidemiology 1992;11:80-83.
9. 9. Nilsson LV. Incidence of severe dementia in an urban sample followed from 70 to 79 years of age. Acta Psych Scand 1984;70:478-486.
10. 10. U.S. Bureau of the Census. Current Population Reports, Special Studies, P23-190, 65+ in the United States. Washington, DC: U.S. Government Printing Office; 1996.
11. 11. Jaffe AB, Toran-Allerand CD, Greengard P, et al. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 1994;269:13065-13068.
12. 12. Josefsson E, Tarkowski A, Carlsten H. Anti-inflammatory properties of estrogen. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neurtrophils. Cell Immunol 1992;142:67-78.
13. 13. Singh M, Meyer EM, Millard WJ, et al. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 1994;644:305-312.
14. 14. Gibbs RB, Wu D, Hersh LB, et al. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation in adult rats. Exp Neurol 1994;129:70-80.
15. 15. Toran-Allerand CD, Miranda RC, Bentham WD, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992;89:4668-4672.
16. 16. Singh M, Meyer EM, Simpkins JW. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 1995;136:2320-2324.
17. 17. Toran-Allerand CD. Mechanisms of estrogen action during neural development: mediation by interaction with the neurotrophins and their receptors. J Ster Biochem Mol Biol 1996;56:169-178.
18. 18. Woolley CS, McEwen BS. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992;12:2549-2554.
19. 19. Murphy DD, Segal M. Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 1996;16:4059-4068.
20. 20. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 1994; 14:7680-7687.
21. 21. Matsumoto A, Arai Y, Osanai M. Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats. Neurosci Res 1985;2:412-418.
22. 22. Funk JL, Mortel KF, Meyer JS. Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women. Dementia 1991;2:268-272.
23. 23. Hackman BW, Galbraith D. Replacement therapy with piperazine oestrone sulphate ("Harmongen") and its effect on memory. Curr Med Res Opin 1976;4:303-306.
24. 24. Malleson J. An endocrine factor in certain affective disorders. Lancet ii 1953;158-164.
25. 25. Van Keep PA. The history and rationale of hormone replacement therapy. Maturitas 1990;12:163-170.
26. 26. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977;4:31-47.
27. 27. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
28. 28. Hampson E, Kimura D. Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav Neurosci 1988;102:456-459.
29. 29. Kimura D, Hampson E. Cognitive pattern in men and women is influenced by fluctuations in sex hormones. Cur Dir Psycholog Sci 1994;3:57-61.
30. 30. Henderson VW, Paganini-Hill A, Emanuel CK, et al. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 1994;51:896-900.
31. 31. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-261.
32. 32. Graves AB, White E, Koepsell TD, et al. A case-control study of Alzheimer's disease. Ann Neurol 1990;28:766-774.
33. 33. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
34. 34. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 1986;11:337-345.
35. 35. Fillit H. Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women. Ann N Y Acad Sci 1994;743:233-238.
36. 36. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;269:2637-2641.
37. 37. Honjo H, Ogino Y, Tanaka K, et al. An effect of conjugated estrogen to cognitive impairment in women with senile dementia - Alzheimer's type: a placebo-controlled double-blind study. J Jpn Menopause Soc 1993;1:167-171.
38. 38. Ohkura T, Isse K, Akawawa K, et al. Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause 1994;1:125-130.
39. 39. Cox DR. Regression models and life tables. J R Statist Soc B 1972;34:187-195.
40. 40. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics 1983;39:499-503.
41. 41. The Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Controlled Clin Trials 1998;19:61-109.
42. 42. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry 1987;48:314-318.
43. 43. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349:1793-1796.
44. 44. Tombaugh TN, McDowell I, Kristjansson B, et al. Mini-mental state examination (MMSE) and the modified MMSE (3MS): a psychometric comparison and normative data. Psychol Assess 1996;8:48-59.
45. 45. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
46. 46. Army Individual Test Battery. Manual of Directions and Scoring. Washington, DC: War Department, Adjutant General's Office; 1944.
47. 47. Lesak MD. Neuropsychological Assessment, 2nd ed. New York: Oxford University Press; 1983.
48. 48. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994; 272:1749-1756.
49. 49. Yesavage JA, Brink TL, Rose TL, et al. The Geriatric Depression Scale: Comparison with other self-report and psychiatric rating scales. In: Crook T, Ferris S, Bartus R, eds. Assessment in Geriatric Psychopharmacology. New Canaan, CT: Mark Powley Associates; 1983:153-157.
50. 50. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12:189-198.
51. 51. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
52. 52. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;8:699-721.
53. 53. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
54. 54. Link WA. A model for informative censoring. J Am Statist Assoc 1989;84:749-756.
55. 55. Wu MC, Bailey KR. Analyzing changes in the presence of informative right censoring caused by death and withdrawal. Stat Med 1988;7:337-344.
56. 56. Laird NM, Oliver D. Covariance analysis of censored survival data using log-linear analysis techniques. J Am Statist Assoc 1981;76:231-239.
57. 57. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
58. 58. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
59. 59. Tsay RS. Regression models with time series errors. J Am Statist Assoc 1984;79:18-24.
60. 60. Little RJA. Pattern mixture models for multivariate incomplete data. J Am Statist Assoc 1993;88:125-134.
61. 61. D'Agostino RB Jr, Dawson R. Propensity score techniques for estimating treatment effects in clinical trials with dropouts. Controlled Clin Trials 1997;18(3S):1035.